Oncology Consultants Research (P1 Trials)

Houston, Texas 77030

1 studies enrolling now · 1 studies all time

What they study most

ALK-Positive Lung Cancer, ALK-positive NSCLC, ALK-positive Non-small Cell Lung Cancer

Studies at this site

• A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC — Recruiting now